![](/img/cover-not-exists.png)
Addition of cetuximab to first-line chemotherapy in patients with advanced non-small-cell lung cancer: a cost-utility analysis
Joerger, M., Matter-Walstra, K., Fruh, M., Kuhnel, U., Szucs, T., Pestalozzi, B., Schwenkglenks, M.Volume:
22
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdq431
Date:
March, 2011
File:
PDF, 186 KB
english, 2011